Annual report
4893.TEDINET S100T6PI
Period2023-01-01 → 2023-12-31
Filed2024-03-29
StandardJapan GAAP
ConsolidatedNo
Data checks11 of 11 passed
Key figures · 73
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥317m | 2023-01-01 → 2023-12-31 | Standalone | Operating revenues (key data) |
| Revenue | ¥626m | 2022-01-01 → 2022-12-31 | Standalone | Operating revenues (key data) |
| Revenue | ¥101m | 2021-01-01 → 2021-12-31d | Standalone | Operating revenues (key data) |
| Revenue | ¥97m | 2020-01-01 → 2020-12-31d | Standalone | Operating revenues (key data) |
| Revenue | ¥521m | 2019-01-01 → 2019-12-31d | Standalone | Operating revenues (key data) |
| Operating income | −¥775m | 2023-01-01 → 2023-12-31 | Standalone | Operating income |
| Operating income | −¥106m | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Ordinary income | −¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥384m | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥793m | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥605m | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥57m | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Income before income taxes |
| Profit before tax | −¥384m | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Net income | −¥1.1bn | 2023-01-01 → 2023-12-31 | Standalone | Profit loss |
| Net income | −¥387m | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | −¥795m | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥637m | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥55m | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.8bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥4.3bn | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.7bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.3bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥91m | at 2023-12-31 | Standalone | Liabilities |
| Total liabilities | ¥340m | at 2022-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥5.7bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥4.3bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥4.2bn | at 2021-12-31d | Standalone | Net assets |
| Net assets / equity | ¥2.6bn | at 2020-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥2.2bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥5.6bn | at 2023-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.5bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥5.6bn | at 2023-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.5bn | at 2022-12-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥4.1bn | at 2021-12-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2020-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥873m | 2023-01-01 → 2023-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥107m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥777m | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥301m | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5m | 2023-01-01 → 2023-12-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥4m | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥1.9bn | 2023-01-01 → 2023-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥488m | 2022-01-01 → 2022-12-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥2.4bn | 2021-01-01 → 2021-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥996m | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-27.25 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-9.87 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.75 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-89.64 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.99 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥131.26 | at 2023-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥108.48 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥107.3 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥361.19 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥323.37 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 98.3% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 92.5% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.9% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.0% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.3% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.5% | 2019-01-01 → 2019-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 43,276,765 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 39,579,865 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 38,958,665 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,179,868 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,896,020 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 28 | at 2023-12-31 | Standalone | Number of employees |
| Employees | 19 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 14 | at 2021-12-31d | Standalone | Number of employees |
| Employees | 12 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 8 | at 2019-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 683
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes financial instruments financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes share options etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYearDuration_NonConsolidatedMember | Original text (Japanese)当社は、がん免疫療法創薬事業の単一セグメントであり、セグメント情報の記載を省略しております。 | |
| Information for each product or service (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | Prior1YearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each product or service (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Revenues from external customers information for each region (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Information for each of main customers (text) | CurrentYearDuration_NonConsolidatedMember | Text · Plus | |
| Notes related parties financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes per share information financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes significant events after reporting period financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of property plant and equipment etc (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of corporate bonds financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of borrowings financial statements (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of provisions (text) | CurrentYearDuration | Text · Plus | |
| Annexed detailed schedule of asset retirement obligations financial statements (text) | CurrentYearDuration | Text · Plus | |
| Components of major assets and liabilities (text) | CurrentYearDuration | Text · Plus | |
| Other information financial statements etc (text) | CurrentYearDuration | Text · Plus | |
| Overview of operational procedures for shares (text) | FilingDateInstant | Text · Plus | |
| Information about parent company etc of reporting company (text) | FilingDateInstant | Text · Plus | |
| Other reference information (text) | FilingDateInstant | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |